【24h】

'Artificial' Hemodialysis Versus 'Natural' Hemofiltration

机译:“人工”血液透析与“自然”血液滤过

获取原文
获取原文并翻译 | 示例
           

摘要

Because the native kidney is a filter and does not engage in the process of dialysis, long-held beliefs in the superiority of blood filtration for eliminating uremic toxins have rarely been challenged. What could be better than the divine prototype?In the early 1960s, shortly after hemodialysis (HD) was first applied as a life-sustaining therapy for patients with chronic irreversible kidney failure, it became clear that the astonishing life-saving effects of HD could not be extended to restore a normal quality of life. Patients continued to suffer from lethargy, poor appetite, occasional nausea and vomiting, and inability to concentrate and function on a par with coworkers. Mortality rates were, and continue to be, much higher than in the general population. The logical answer to the "why" question was that the therapy was incomplete. However, attempts during the late 1960s and early 1970s to increase the intensity or "dose" of dialysis with higher blood and dialysate flow rates, larger membranes, and longer treatment times failed to bring about the desired improvement in outcome. Although early work with dialysis was hampered by adverse effects of the dialysis itself, the original pioneers (as well as some present-day dialysis clinicians) concluded that inadequate removal of toxic large molecules was responsible at least in part for these disappointing results. Early reports of new highly permeable membranes made from synthetic polyacrylonitrile that could cure uremic neuropathy, a uremic complication previously thought to be reversed only by renal transplantation, spurred efforts to develop membranes and delivery systems aimed at removing larger molecules.
机译:由于天然肾脏是过滤器,并且不参与透析过程,因此长期以来一直坚信血液过滤在消除尿毒症毒素方面的优越性。有什么能比神圣的原型更好呢?1960年代初期,血液透析(HD)首次被用作慢性不可逆性肾衰竭患者的维持生命的疗法后,很明显,HD的惊人的挽救生命的作用可以无法延长以恢复正常的生活质量。患者继续遭受嗜睡,食欲不振,偶尔出现的恶心和呕吐以及无法集中精力和与同事保持同等水平的痛苦。死亡率一直以来都比普通人群高得多。对于“为什么”问题的合乎逻辑的答案是治疗不完全。然而,在1960年代末和1970年代初,试图通过更高的血液和透析液流速,更大的膜和更长的治疗时间来增加透析的强度或“剂量”,未能带来预期的结果改善。尽管透析的早期工作因透析本身的不利影响而受阻,但最初的先驱者(以及一些当今​​的透析临床医生)得出结论认为,有毒大分子的去除不足至少部分是造成这些令人失望的结果的原因。由合成聚丙烯腈制成的新型高渗透性膜的早期报道可以治愈尿毒症神经病(以前被认为只能通过肾脏移植才能逆转的尿毒症并发症),促使人们致力于开发旨在去除较大分子的膜和递送系统。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号